Japan Lifeline Co., Ltd. Provides Earnings Guidance for the Second Quarter and Year Ending March 31, 2023
May 11, 2022 at 02:10 am EDT
Share
Japan Lifeline Co., Ltd. provided earnings guidance for the second quarter and year ending March 31, 2023. For the quarter, company expects net sales to be JPY 24,861 million, operating profit to be JPY 4,403 million, profit attributable to owners of parent to be JPY 3,193 million and earnings per share to be JPY 40.74.
For the year, company expects net sales to be JPY 51,527 million, operating profit to be JPY 10,011 million, profit attributable to owners of parent to be JPY 7,274 million and earnings per share to be JPY 93.06.
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.
JAPAN LIFELINE CO., LTD. 
